Bradley (Brad) Fleugel
Brad Fluegel currently advises health care organizations, entrepreneurs, and other participants in health care. He was most recently the senior vice president - chief healthcare commercial market development officer for Walgreens. Brad was responsible for all commercial healthcare activities, including sales and contracting, biopharma relationships, retail clinics, clinical affairs, new service development and market planning. Previously, he was Chief Strategy and Business Development officer for Walgreens, responsible for corporate strategy and business development.
Brad joined Walgreens in October 2012 after serving as executive in residence at Health Evolution Partners. Before that he was executive vice president and chief strategy and external affairs officer of Anthem and senior vice president of national accounts and vice president, enterprise strategy at Aetna. Earlier, Brad was CEO for Reden & Anders (Optum Consulting) and Tillinghast-Towers Perrin, a clinical, actuarial and management consulting practice that served all sectors of the health care industry. While there, he negotiated the sale of Tillinghast Health to Optum. He also held several roles in strategy and product development at Harvard Community Health Plan and organized and led audits, feasibility studies and related projects for health care clients at Arthur Andersen & Co.
Brad currently serves on the Board of Directors of Metropolitan Jewish Health System in New York City, Performant Financial Corporation, Fitbit, Premera Blue Cross and Alight Solutions. He also advises several health care companies and private equity firms.
Brad earned a Master’s degree in public policy from Harvard University’s Kennedy School of Government and a bachelor of arts in business administration from the University of Washington. He also serves as a lecturer at the University of Pennsylvania’s Wharton School of Business.